Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes

European Journal of Pharmacology

Volumn 333, Issue 2-3, 1997, Pages 249-259

  Yokoshiki, Hisashi ^a   Katsube, Yasuhiro ^a   Sunagawa, Masanori ^a   Sperelakis, Nicholas ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

K+ channel; K+ channel ATP sensitive; Levosimendan; Mesenteric artery; Patch clamp technique; Rat

Indexed keywords

GLIBENCLAMIDE; LEVOSIMENDAN; POTASSIUM CHANNEL; 1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ANTIDIABETIC AGENT; CHARYBDOTOXIN; ENZYME INHIBITOR; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN; VASODILATOR AGENT;

ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; MALE; MEMBRANE STEADY POTENTIAL; MUSCLE CELL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; ANIMAL; CELL MEMBRANE POTENTIAL; DRUG ANTAGONISM; DRUG EFFECT; MESENTERIC ARTERY;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANIMALS; CELLS, CULTURED; CHARYBDOTOXIN; ENZYME INHIBITORS; FEMALE; GLYBURIDE; HYDRAZONES; HYPOGLYCEMIC AGENTS; MALE; MEMBRANE POTENTIALS; MESENTERIC ARTERIES; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; PYRIDAZINES; RATS; VASODILATOR AGENTS;

EID: 0030608872     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01108-4     Document Type: Article

References (59)

1. Aguilar-Bryan L., Nicholas C.G., Wechsler S.W., Clement IV J.P., Boyd III A.E., Gonzalez G., Herrera-Sosa H., Nguy K., Bryan J., Nelson D.A. Cloning of the β cell high-affinity sulfonylurea receptor: A regulator of insulin secretion. Science. 268:1995;423-426.
2. Beech D.J., Zhang H., Nakao K., Bolton T.B. K channel activation by nucleotide diphosphates and its inhibition by glibenclamide in vascular smooth muscle cells. Br. J. Pharmacol. 110:1993;573-582.
3. Beech D.J., Zhang H., Nakao K., Bolton T.B. Single channel and whole-cell K-currents evoked by levocromakalim in smooth muscle cells from the rabbit portal vein. Br. J. Pharmacol. 110:1993;583-590.
4. + channels regulate resting potential of pulmonary arterial smooth muscle cells. Am. J. Physiol. 262:1992;H916-H920.
5. Cohn J.N., Archibald D.G., Ziesche S., Franciosa J.A., Harston W.E., Tristani F.E., Dunkman W.B., Jacobs W., Francis G.S., Flohr K.H., Goldman S., Cobb F.R., Shah P.M., Saunders R., Fletcher R.D., Loeb H.S., Hughes V.C., Baker B. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N. Engl. J. Med. 314:1986;1547-1552.
6. Cohn J.A., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W.B., Loeb H., Wong M., Bhat G., Goldman S., Fletcher R.D., Doherty J., Hughes V., Carson P., Cintron G., Shabetani R., Haakenson C. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N. Engl. J. Med. 325:1991;303-310.
7. Dart C., Standen N.B. Adenosine-activated potassium current in smooth muscle cells isolated from the pig coronary artery. J. Physiol. London. 471:1993;767-786.
8. + channels by hypoxia in smooth muscle cells isolated from the pig coronary artery. J. Physiol. London. 483:1995;29-39.
9. ATP channels and basal coronary vascular tone. Cardiovasc. Res. 28:1994;811-817.
10. Eckman D.M., Frankovich J.D., Keef K.D. Comparison of the actions of acetylcholine and BRL 38227 in the guinea-pig coronary artery. Br. J. Pharmacol. 106:1992;9-16.
11. 2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart. Circ. Res. 77:1995;107-113.
12. Edwards G., Weston A.H. The pharmacology of ATP-sensitive potassium channels. Annu. Rev. Pharmacol. Toxicol. 33:1993;597-637.
13. + channel and enhanced vascular smooth muscle relaxation in genetically hypertensive rats. J. Hypertens. 11:1993;1067-1072.
14. Haikala H., Kaivola J., Nissinen E., Wall P., Levijoki J., Linden I.-B. Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. J. Mol. Cell. Cardiol. 27:1995;1859-1866.
15. Harkin C.P., Pagel P.S., Tessmer J.P., Warltier D.C. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs. J. Cardiovasc. Pharmacol. 26:1995;179-188.
16. Imamura Y., Tomoike H., Narishige T., Takahashi T., Kasuya H., Takeshita A. Glibenclamide decreases basal coronary blood flow in anesthetized dogs. Am. J. Physiol. 263:1992;H399-H404.
17. KATP: An inward rectifier subunit plus the sulfonylurea receptor. Science. 270:1995;1166-1170.
18. + channels. Neuron. 16:1996;10111017.
19. + channel. J. Biol. Chem. 271:1996;24321-24324.
20. + channel in the rabbit portal vein. J. Physiol. London. 444:1991;397-418.
21. Kakei M., Noma A., Shibasaki T. Properties of adenosine-triphosphate-regulated potassium channels in guinea-pig ventricular cells. J. Physiol. London. 363:1985;441-462.
22. + channels in cultured vascular smooth muscle cells. Circ. Res. 74:1994;471-476.
23. Leech C.J., Faber J.E. Differential sensitivity of venular and arteriolar α-adrenergic receptor constriction to inhibition by hypoxia. Role of receptor subtype and coupling heterogeneity. Circ. Res. 78:1996;1064-1074.
24. Lilleberg J., Sundberg S., Nieminen M.S. Dose-range study of a new calcium sensitizer, levosimendan, in patients with left ventricular dysfunction. J. Cardiovasc. Pharmacol. 26 (Suppl. 1):1995;S63-S69.
25. + channels in the rabbit. J. Clin. Invest. 90:1992;733-740.
26. + channel opened by cromakalim. Br. J. Pharmacol. 103:1991;1184-1190.
27. + channels by cyclic AMP-dependent protein kinase in cultured smooth muscle cells of porcine coronary artery. Biochem. Biophys. Res. Commun. 193:1993;240-247.
28. + channel of vascular smooth muscle cells. FEBS Lett. 345:1994;47-49.
29. Murphy M.E., Brayden J.E. Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J. Physiol. London. 486:1995;47-58.
30. + channels in the vertebrobasilar system of the rabbit. Circ. Res. 78:1996;238-243.
31. Nakae I., Takahashi M., Takaoka A., Liu Q., Matsumoto T., Amano M., Sekine A., Nakajima H., Kinoshita M. Coronary effects of diadenosine tetraphosphate resemble those of adenosine in anesthetized pigs: Involvement of ATP-sensitive potassium channels. J. Cardiovasc. Pharmacol. 28:1996;124-133.
32. Nelson M.T., Quayle J.M. Physiological roles and properties of potassium channels in arterial smooth muscle. Am. J. Physiol. 268:1995;C799-C822.
33. + channels. Nature. 344:1990;770-773.
34. Nielsen-Kudsk J.E., Aldershvile J. Will calcium sensitizers play a role in the treatment of heart failure? J. Cardiovasc. Pharmacol. 26 (Suppl. 1):1995;S77-S84.
35. Ohya Y., Sperelakis N. ATP regulation of the slow calcium channels in vascular smooth muscle cells of guinea pig mesenteric artery. Circ. Res. 64:1989;145-154.
36. Ohya Y., Sperelakis N. Modulation of single slow (L-type) calcium channels by intracellular ATP in vascular smooth muscle cells. Pflugers Arch. 414:1989;257-264.
37. Packer M. Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hope. J. Am. Coll. Cardiol. 12:1988;1299-1317.
38. Pagel P.S., Harkin C.P., Hettrick D.A., Warltier D.C. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs. J. Pharmacol. Exp. Ther. 275:1995;127-135.
39. + channels in vascular smooth muscle cells of the guinea pig portal vein. Pfluger Arch. 423:1993;149-151.
40. 2+ sensitizer, levosimendan, to recombinant human cardiac troponic C. J. Biol. Chem. 269:1994;28584-28590.
41. Quast U., Guillon J.-M., Cavero I. Cellular pharmacology of potassium channel openers in vascular smooth muscle. Cardiovasc. Res. 28:1994;805-810.
42. ATP channels in vascular smooth muscle. Cardiovasc. Res. 28:1994;797-804.
43. + currents in rabbit arterial smooth muscle via protein kinase A. J. Physiol. London. 475:1994;9-13.
44. Samaha F.F., Heineman F.W., Ince C., Fleming J., Baraban R.S. ATP-sensitive potassium channel is essential to maintain basal coronary vascular tone in vivo. Am. J. Physiol. 262:1992;C1220-C1227.
45. + channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents. J. Gen. Physiol. 100:1992;573-591.
46. + channels in arterial smooth muscle. Science. 245:1989;177-180.
47. Sundberg S., Lilleberg J., Nieminen M.S., Lehtonen L. Hemodynamic and neurohumoral effects of levosimendan, a new calcium sensitizer, at rest and during exercise in healthy men. Am. J. Cardiol. 75:1995;1061-1066.
48. + channel-opening drugs. Am. J. Physiol. 269:1995;C525-C545.
49. The CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N. Engl. J. Med. 316:1987;1429-1435.
50. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N. Engl. J. Med. 325:1991;293-302.
51. - conductance. Circ. Res. 77:1995;417-423.
52. Udvary E., Papp J.G., Vegh A. Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction. Br. J. Pharmacol. 114:1995;656-661.
53. Vegh A., Papp J.G., Udvary E., Kaszala K. Hemodynamic effects of calcium-sensitizing agents. J. Cardiovasc. Pharmacol. 26 (Suppl. 1):1995;S20-S31.
54. + currents in smooth muscle cells of intact rat small arteries. J. Physiol. London. 500:1997;617-630.
55. 2+ channel currents by intracellular ATP in smooth muscle cells of rat mesenteric artery. Am. J. Physiol. 272:1997;H814-H819.
56. + channel in rat ventricular cells. J. Pharmacol. Exp. Ther., in press.
57. i in pulmonary arterial myocytes. Circ. Res. 77:1995;370-378.
58. Zhang H., Bolton T.B. Activation by intracellular GDP, metabolic inhibition and pinacidil of a glibenclamide-sensitive K-channel in smooth muscle cells of rat mesenteric artery. Br. J. Pharmacol. 114:1995;662-672.
59. Zhang H.-L., Bolton T.B. Two types of ATP-sensitive potassium channels in rat portal vein smooth muscle cells. Br. J. Pharmacol. 118:1996;105-114.